Clinical Trials in Los Angeles

Showing 2541-2560 of 8,046 trials

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

NCT05509855

This study will provide long-term follow-up for patients who have received treatment with WU-CART-007 in a previous clinical trial. In this study, patients will be followed for up to 15 years after their last dose of WU-CART-007 for evaluation of delayed adverse events, presence of persisting WU-CART-007 vector sequences, and overall survival and progression-free survival.

T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma

Wugen, Inc.44 participantsStarted Aug 2022

Duarte, California, United States • Los Angeles, California, United States • St Louis, Missouri, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

NCT01064622

This randomized phase I/II trial studies gemcitabine hydrochloride and vismodegib to see how well they work compared with gemcitabine hydrochloride alone in treating patients with recurrent or metastatic pancreatic cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Vismodegib may slow the growth of tumor cells. It is not yet known whether giving gemcitabine hydrochloride together with vismodegib is more effective than gemcitabine hydrochloride alone in treating patients with pancreatic cancer.

Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7

National Cancer Institute (NCI)118 participantsStarted Sep 2009

Beverly Hills, California, United States • Duarte, California, United States • Los Angeles, California, United States +22 more locations

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Find Trials by Condition in Los Angeles

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

Dashboard Activated Services and Tele-Health for Heart Failure

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

Discontinuation of Hypnotics in Older Veterans

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

An Investigation of the Effects of a Skin Serum Containing Propolis on Skin Health and Appearance

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Comparing TR Band to Statseal in Conjunction With TR Band II

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

LEV102 Topical Gel in Acquired Blepharoptosis

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies